Fidaxomicin’s Role in Overcoming Vancomycin Failure in Clostridium difficile Infections: A Case Series and Literature Review

TL;DR

This paper discusses the use of fidaxomicin after vancomycin fails in treating Clostridium difficile infections and highlights the need for more research on its effectiveness.

Contribution

The paper presents a case series and literature review to emphasize the need for large studies comparing fidaxomicin and vancomycin.

Findings

Five patients with CDI were treated with fidaxomicin after vancomycin failed.

Current literature does not show fidaxomicin is more effective than vancomycin for acute CDI.

The paper calls for larger studies to determine the relative effectiveness of the two treatments.

Abstract

Clostridium difficile infection (CDI), characterized by diarrheal illness with serious complications, is a common pathology in clinical practice. We present a series of five patients with CDI who underwent treatment with fidaxomicin following the failure of oral vancomycin. To our knowledge, no evidence in the literature suggests that fidaxomicin is more effective than vancomycin in treating acute infection. This paper emphasizes the importance of utilizing a large study to determine the relative effectiveness of vancomycin versus fidaxomicin in treating CDI. We also provide a literature review on CDI and management evolution.

Figures